科博達(603786.SH)擬註銷子公司温州科博達工業
格隆匯 8 月 19日丨科博達(603786.SH)公佈,公司於2020年8月18日召開第二屆董事會第二次會議,審議通過了《關於註銷子公司的議案》,同意公司註銷温州科博達工業技術有限公司(“温州科博達工業”)。
基於公司整體經營規劃和戰略佈局,為進一步整合及優化公司資源配置和管理架構,降低管理成本,提升運營效率,經審慎研究,公司決定註銷温州科博達工業,並授權公司管理層依法辦理相關清算和註銷事宜。
此次擬註銷的温州科博達工業無實際經營業務,不會對公司整體業務發展產生影響,不會損害公司及全體股東的利益。註銷完成後,公司合併報表範圍將發生相應變化,但不會對公司合併報表產生實質影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.